Abstract

Histological features of very early-onset compared to later-onset inflammatory bowel diseases: A multicenter retrospective study.

Dalpiaz, Irene (I);Scarallo, Luca (L);Alvisi, Patrizia (P);Onofrio, Jessica Naso (JN);Bedeschi, Arianna (A);Renzo, Sara (S);Villanacci, Vincenzo (V);Lionetti, Paolo (P);

 
     

Author information

J Pediatr Gastroenterol Nutr.2025 Jun 11;81(2):286-294.doi:10.1002/jpn3.70110

Abstract

OBJECTIVES: To identify and describe endoscopic and histological features of children with non-monogenic very early-onset inflammatory bowel diseases (VEO-IBD) compared to endoscopic and histological features of children with later-onset (LO-IBD).

METHODS: A multicenter retrospective observational study in two Italian Pediatric IBD referral centers was done. Patients with VEO-IBD were matched with LO-IBD controls with a similar disease phenotype, with a 1:1 ratio for ulcerative colitis (UC) and 1:2 for Crohn's disease (CD). Clinical, endoscopic, and histological data were retrospectively collected.

RESULTS: Fifty-three children with VEO-IBD, 42 UC, 11 CD, and 68 with LO-IBD (44 UC and 24 CD) were identified. Patients with VEO-CD had more frequently isolated colonic disease compared to those with LO-CD (p = 0.002), whereas patients with VEO-UC had more frequent pancolonic involvement (p = 0.05). As regards histologic findings, basal plasmacytosis intermingled with eosinophils, goblet cells depletion, active inflammation, and crypt architectural distortion were significantly more frequent in patients with LO-UC compared to VEO-UC (83.7% vs. 61.9%, p = 0.021, 100.0% vs. 73.8%, p < 0.001, 86.4% vs. 66.7%, p = 0.028), while in CD, skip lesions were more frequent in LO-CD than in VEO-CD (83.3% vs. 45.5%, p = 0.031).

CONCLUSIONS: VEO-IBD and LO-IBD exhibit different phenotypes with regard to disease localization and histological features. Younger children with UC exhibit a lower histological burden than those with LO-UC, whereas typical characteristics of CD are rarely observed in VEO-CD.

© Copyright 2013-2026 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.